Literature DB >> 10516870

Effect of antihypertensive therapy on aortic distensibility in patients with essential hypertension: comparison with trichlormethiazide, nicardipine and alacepril.

T Honda1, M Hamada, Y Shigematsu, Y Matsumoto, H Matsuoka, K Hiwada.   

Abstract

To assess the effect of antihypertensive drugs on aortic distensibility, we evaluated the aortic distensibility of 33 hypertensive patients before and after antihypertensive treatment by using cine magnetic resonance imaging. Thirty three hypertensive patients were divided into three groups and treated for 12 weeks with 2-4 mg trichlormethiazide per day (n = 10), 80 mg nicardipine per day (n = 13) and 50 mg alacepril per day (n = 10). There were no significant differences in mean age and mean blood pressure among the three groups. Cine magnetic resonance was performed at ascending and descending aortic levels. Aortic area was measured at the maximum and minimum frames. The effect of antihypertensive therapy on aortic distensibility was evaluated as the percent change from before treatment to after treatment. There were no significant differences in pulse pressure before and after treatment with trichlormethiazide, nicardipine and alacepril. After treatment with these drugs, mean blood pressure in all groups decreased (trichlormethiazide and nicardipine, P < .01; alacepril, P < .05), (the maximum area--the minimum area) and aortic distensibility in all groups increased significantly (each P < .01). Percent changes in aortic distensibility after treatment were significantly higher with nicardipine (ascending, 346.6 +/- 255.9%; descending, 338.8 +/- 246.5%, each P < .05) and alacepril (ascending, 369.7 +/- 238.8%, P < .05; descending, 306.9 +/- 123.3%, P < .01) than with trichlormethiazide (ascending, 146.0 +/- 139.6%; descending, 129.3 +/- 97.5%). In conclusion, nicardipine and alacepril have a beneficial effect on aortic distensibility.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516870     DOI: 10.1023/a:1007711617112

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  4 in total

1.  Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion catheters.

Authors:  Q Zhong; B C Yoon; M Aryal; J B Wang; T Ilovitsh; M A Baikoghli; N Hosseini-Nassab; A Karthik; R H Cheng; K W Ferrara; R D Airan
Journal:  Biomaterials       Date:  2019-03-20       Impact factor: 12.479

Review 2.  Effect of angiotensin-converting enzyme inhibitors on arterial stiffness in hypertension: systematic review and meta-analysis.

Authors:  Madhavi Mallareddy; Chirag R Parikh; Aldo J Peixoto
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-06       Impact factor: 3.738

3.  Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change.

Authors:  Sudeep R Aryal; Mohammed Siddiqui; Oleg F Sharifov; Megan D Coffin; Bin Zhang; Krishna K Gaddam; Himanshu Gupta; Thomas S Denney; Louis J Dell'Italia; Suzanne Oparil; David A Calhoun; Steven G Lloyd
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

4.  Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease.

Authors:  Patrick B Mark; Arthur Doyle; Kevin G Blyth; Rajan K Patel; Robin A P Weir; Tracey Steedman; John E Foster; Henry J Dargie; Alan G Jardine
Journal:  J Cardiovasc Magn Reson       Date:  2008-08-18       Impact factor: 5.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.